Who
Cristian Luput
Director
Company insider
Files Form 4 as: Director, MAIA Biotechnology.
In numbers
- Trades disclosed
- 42
- Buys
- 21
- Sells
- 0
- Bought
- $266K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Aug 2022
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,536 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,610 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,610 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,556 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,556 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,206 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,206 at $0.00 | filing |
| 28 Nov 2025filed 1 Dec 2025 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $20K18,145 at $1.11 | filing |
| 26 Nov 2025filed 1 Dec 2025 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $22K20,000 at $1.08 | filing |
| 25 Nov 2025filed 28 Nov 2025 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $9,80010,000 at $0.98 | filing |
| 2 Oct 2025filed 6 Oct 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,434 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,350 at $0.00 | filing |
| 4 Apr 2025filed 8 Apr 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,042 at $0.00 | filing |
| 31 Dec 2024filed 3 Jan 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,225 at $0.00 | filing |
| 1 Nov 2024filed 4 Nov 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code P | $50K22,133 at $2.26 | filing |
| 1 Nov 2024filed 4 Nov 2024 | MAIA MAIA BiotechnologyBiotechnology | SEC FORM 4 Bought | $56K22,133 at $2.51 | filing |
| 30 Sep 2024filed 2 Oct 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,232 at $0.00 | filing |
| 30 Jun 2024filed 2 Jul 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,728 at $0.00 | filing |
| 31 Mar 2024filed 2 Apr 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,193 at $0.00 | filing |
| 14 Mar 2024filed 15 Mar 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code P | $90K69,282 at $1.30 | filing |
News
MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Up 0.8% – Here's What HappenedMAIA · dailypolitical.com · 8 Oct 2026MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung CancerMAIA · manilatimes.net · 7 Oct 2026
0 headlines in the last 90 days name Cristian Luput; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.